Pharma Reviews: Mylan to invest $6 billion on capex in India to incentivise R&D activities

Multinational drug company Mylan is all set to invest on capex in India. It has said it will invest $1 billion in the next 5-6 years on it, considering the ...
Read more: Mylan to invest $6 billion on capex in India to incentivise R&D activities